The long-term goal of our work is to understand the mechanism of transcriptional regulation by steroid hormone receptors and their dysregulation during disease. We seek to reveal how specific coactivators and corepressors translate the hormonal signals into promoter-dependent transcriptional outputs. Our work centers on the mechanism of gene activation by the glucocorticoid receptor (GR). GR harbors two major transcriptional activation functions (AF1 and AF2) that are differentially utilized in individual promoter and cellular contexts. In contrast to the C-terminal AF2 function, little is known regarding the coregulators that interact with, and mediate the functions of the N-terminal AF1. This region plays key roles in important therapeutic effects of glucocorticoids such as the induction of thymocyte apoptosis. We recently generated specific mutations in AF1 that pinpoint the critical residues responsible for function. We have used them in complementary approaches to discover AF1 coregulators. In a genetic approach, we isolated two extragenic suppressor yeast strains where the function of deficient AF1 mutants is restored. The genes responsible are likely to encode conserved factors intimately involved in AF1 function. Through an independent functional approach, we identified the 150kDa subunit of the DRIP/TRAP/Mediator complex as a protein that interacts with a transcriptionally competent AF1.
In Aim 1, we propose to define the nature and structural basis for the interaction of DRIP 150 with GR AF1. We plan to map the minimal regions necessary in each protein and identify key residues through random and targeted mutagenesis coupled with screening in yeast. We will explore the structural basis of the interaction through a biophysical characterization of the complex.
In Aim 2, we will ascertain the functional consequences of AF1 binding to DRIP 150 and define the effector regions of DRIP 150 involved in transcriptional activation. Using multiple approaches, we will test the hypothesis that AF1 recruitment of the DRIP complex determines whether GR activation of a given promoter requires participation of AF1.
In Aim 3, we propose to identify novel conserved AF1 coregulators by cloning the genes responsible for the extragenic suppression in the yeast strains we have isolated. We will then identify mammalian counterparts and begin to ascertain their role in AF1 function using some of the assays outlined in Aims 1 and 2.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK061656-03
Application #
6712818
Study Section
Endocrinology Study Section (END)
Program Officer
Margolis, Ronald N
Project Start
2002-04-22
Project End
2007-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
3
Fiscal Year
2004
Total Cost
$237,448
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Mukherjee, Sarmistha; Cruz-Rodríguez, Osvaldo; Bolton, Eric et al. (2012) The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs. J Biol Chem 287:31195-206
Jenkins, Paul M; McIntyre, Jeremy C; Zhang, Lian et al. (2011) Subunit-dependent axonal trafficking of distinct alpha heteromeric potassium channel complexes. J Neurosci 31:13224-35
Mukherjee, Sarmistha; Thomas, Monzy; Dadgar, Nahid et al. (2009) Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. J Biol Chem 284:21296-306
Yang, Wei-Hsiung; Heaton, Joanne H; Brevig, Holly et al. (2009) SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation. Mol Cell Biol 29:613-25
Figueroa-Romero, Claudia; Iñiguez-Lluhí, Jorge A; Stadler, Julia et al. (2009) SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J 23:3917-27
Cesena, Teresa I; Cui, Tracy Xiao; Piwien-Pilipuk, Graciela et al. (2007) Multiple mechanisms of growth hormone-regulated gene transcription. Mol Genet Metab 90:126-33
McEwen, Dyke P; Schumacher, Sarah M; Li, Qiuju et al. (2007) Rab-GTPase-dependent endocytic recycling of Kv1.5 in atrial myocytes. J Biol Chem 282:29612-20
Benson, Mark D; Li, Qiu-Ju; Kieckhafer, Katherine et al. (2007) SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5. Proc Natl Acad Sci U S A 104:1805-10
Evelyn, Chris R; Wade, Susan M; Wang, Qin et al. (2007) CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther 6:2249-60
Iniguez-Lluhi, Jorge A (2006) For a healthy histone code, a little SUMO in the tail keeps the acetyl away. ACS Chem Biol 1:204-6

Showing the most recent 10 out of 16 publications